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Re. ‘An Online Patient Completed Aberdeen Varicose Vein
Questionnaire Can Help to Guide Primary Care Referrals’
We read with interest the study by Ward et al. concerning
an online completion of the disease speciﬁc quality of life
Aberdeen Varicose Vein questionnaire (AVVQ).1 The study is
thought provoking however surely the use of a non-vali-
dated tool renders such extrapolations moot. Without the
original full questionnaire no comparisons can be drawn.
Multiple other questionnaires exist which do not require
a drawing such as Chronic Lower Limb Venous Insufﬁciency
Questionnaire (CIVIQ)2 or Speciﬁc Quality of Life and
Outcome Response e Vascular (SQOR-V).3 Additionally,
construction of an online drawing tool is now well within
our technological grasp.
CEAP grade 4e6 showed a high prevalence in this study
(42%) with a consequently high average VCSS (mean 18.6).
However, this is not reﬂected in the AVVQ scores (mean
21.8). Additionally the correlation for CEAP and AVVQ
scores is not documented e is this clinically as well as
statistically signiﬁcant? Previous work in our unit has shown
good correlation between the AVVQ and CEAP, and AVVQ
and generic quality of life measures, but poor correlations
between VCSS and AVVQ; VCSS and (SQOR-V); and AVVQ
and SQOR-V.4 Current work being undertaken in our unit
has shown excellent correlation between CIVIQ and AVVQ.5
Most concerningly, however, is the number of patients with
C2S disease (symptomatic disease) for whom the authors feel it
is appropriate to deny intervention (47% of their cohort).This is
in disagreement with extensive work that details the progres-
sion of venous disease6 and the cost of treating only compli-
cated disease,7 not to mention the signiﬁcant quality of life
impairments seen with symptomatic disease8 which improve
with treatment.9 Finally, it has previously been shown that
treating uncomplicated venous disease leads to a greater
improvement than leaving thedisease toprogress topermanent
damage10 e the very patients excluded have the most to gain.
Yours Sincerely,
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Response to ‘Re. An Online Patient Completed Aberdeen
Varicose Vein Questionnaire Can Help to Guide Primary
Care Referrals’
Messers Lane, Franklin and Davies have provided additional
points for discussion which should be considered if the
study is to be repeated. The topic of limiting healthcare is
controversial and we are not surprised that our article
attracted their response.
We agree that the use of the on-line AVVQ tool will result
in patients with C2 disease being denied access to state
funded healthcare with the potential outcomes described.
It was not our decision to limit access to healthcare but that
of the commissioners who set a budget that they could
afford. Whether we agree with the concept of limiting the
treatment of venous disease to certain groups was not
